Literature DB >> 19224387

Angiotensin converting enzyme 2 (ACE2) activity in fetal calf serum: implications for cell culture research.

J S Lubel1, C B Herath, E Velkoska, D J Casley, L M Burrell, P W Angus.   

Abstract

Cell culture experiments often employ the use of culture media that contain fetal calf serum (FCS). The angiotensin peptides angiotensin II and angiotensin 1-7 have opposing effects with angiotensin converting enzyme 2 (ACE2) being the enzyme predominantly responsible for generating angiotensin 1-7 from angiotensin II. The effect of FCS on angiotensin peptides has not previously been described. We have shown that FCS has ACE2 enzyme activity capable of degrading angiotensin II and generating angiotensin 1-7. Researchers should be aware that FCS possesses ACE2 activity and that heat-treating FCS to 56 degrees C only partially inhibits this enzyme activity, whereas heat-treating to 70 degrees C completely abolishes ACE2 activity.

Entities:  

Year:  2009        PMID: 19224387      PMCID: PMC2652558          DOI: 10.1007/s10616-009-9185-0

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  28 in total

1.  Angiotensin-(1-7) inhibits growth of cardiac myocytes through activation of the mas receptor.

Authors:  E Ann Tallant; Carlos M Ferrario; Patricia E Gallagher
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-06-10       Impact factor: 4.733

2.  Angiotensin-(1-7) binds to specific receptors on cardiac fibroblasts to initiate antifibrotic and antitrophic effects.

Authors:  Michikado Iwata; Randy T Cowling; Devorah Gurantz; Cristina Moore; Shen Zhang; Jason X-J Yuan; Barry H Greenberg
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-07-15       Impact factor: 4.733

3.  Inhibitory effect of angiotensin II receptor antagonist on hepatic stellate cell activation in non-alcoholic steatohepatitis.

Authors:  Shiro Yokohama; Yoshihiko Tokusashi; Kimihide Nakamura; Yosui Tamaki; Satoshi Okamoto; Mituyoshi Okada; Kazunobu Aso; Takenao Hasegawa; Masaru Aoshima; Naoyuki Miyokawa; Masakazu Haneda; Masashi Yoneda
Journal:  World J Gastroenterol       Date:  2006-01-14       Impact factor: 5.742

4.  Chronic angiotensin-(1-7) prevents cardiac fibrosis in DOCA-salt model of hypertension.

Authors:  Justin L Grobe; Adam P Mecca; Haoyu Mao; Michael J Katovich
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-01-13       Impact factor: 4.733

5.  Impairment of in vitro and in vivo heart function in angiotensin-(1-7) receptor MAS knockout mice.

Authors:  Robson A S Santos; Carlos H Castro; Elisandra Gava; Sérgio V B Pinheiro; Alvair P Almeida; Renata Dutra de Paula; Jader S Cruz; Anderson S Ramos; Kaleizu T Rosa; Maria C Irigoyen; Michael Bader; Natalia Alenina; Gregory T Kitten; Anderson J Ferreira
Journal:  Hypertension       Date:  2006-03-27       Impact factor: 10.190

6.  Acute kidney injury in the rat causes cardiac remodelling and increases angiotensin-converting enzyme 2 expression.

Authors:  L Burchill; E Velkoska; R G Dean; R A Lew; A I Smith; V Levidiotis; L M Burrell
Journal:  Exp Physiol       Date:  2008-01-25       Impact factor: 2.969

Review 7.  Liver fibrosis: a balance of ACEs?

Authors:  Fiona J Warner; John S Lubel; Geoffrey W McCaughan; Peter W Angus
Journal:  Clin Sci (Lond)       Date:  2007-08       Impact factor: 6.124

Review 8.  Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1-7) in regulation of cardiovascular function.

Authors:  Carlos M Ferrario; Aaron J Trask; Jewell A Jessup
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-07-29       Impact factor: 4.733

9.  Upregulation of hepatic angiotensin-converting enzyme 2 (ACE2) and angiotensin-(1-7) levels in experimental biliary fibrosis.

Authors:  Chandana B Herath; Fiona J Warner; John S Lubel; Rachael G Dean; Zhiyuan Jia; Rebecca A Lew; A Ian Smith; Louise M Burrell; Peter W Angus
Journal:  J Hepatol       Date:  2007-04-02       Impact factor: 25.083

10.  Angiotensin-converting enzyme 2 catalytic activity in human plasma is masked by an endogenous inhibitor.

Authors:  Rebecca A Lew; Fiona J Warner; Iresha Hanchapola; Michael A Yarski; Jay Ramchand; Jay Manohar; Louise M Burrell; A Ian Smith
Journal:  Exp Physiol       Date:  2008-01-25       Impact factor: 2.969

View more
  1 in total

1.  Measurement of Angiotensin Converting Enzyme 2 Activity in Biological Fluid (ACE2).

Authors:  Fengxia Xiao; Kevin D Burns
Journal:  Methods Mol Biol       Date:  2017
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.